|
|
|
| Effect of Bevacizumab Targeted Therapy Combined with Chemotherapy on T Lymphocyte Subsets and Serum Tumor Markers in Patients with Colorectal Cancer |
| LIN Yangxing |
| First-author's address: Gaozhou People's Hospital, Guangdong Province, Gaozhou 525200, China |
|
|
